Fenwick & West represented Coinbase Global, Inc. in the offering. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the...
Coinbase Global’s $1.1 Billion Convertible Notes Offering
AppLovin’ Common Stock Secondary Offering and Share Repurchase
Wilson Sonsini Goodrich & Rosati advised AppLovin Corporation on the deal, and Fenwick & West advised the underwriters. AppLovin Corporation (NASDAQ: APP) (“AppLovin” or the “Company”),...
ARTBIO’s Exclusive Strategic Collaboration with AlphaGen Therapeutics
Goodwin is representing ARTBIO on the matter. AlphaGen Therapeutics (“AlphaGen”), a biopharmaceutical company, and ARTBIO, Inc., a clinical-stage radiopharmaceutical company developing a new class of targeted...
Isomorphic Labs’ Multi-Target Research Collaboration with Novartis
Goodwin advised Isomorphic Labs on its strategic research collaboration with Novartis. Isomorphic Labs has signed a strategic research collaboration with Novartis to discover small molecule therapeutics against...
Novo Nordisk’s Research Collaborations with Omega Therapeutics and Cellarity
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
Biotheus’ Partnership with BioNTech
Goodwin Procter advised Biotheus Inc. on the agreement with BioNTech. Biotheus Inc. announced an exclusive global license and collaboration agreement with BioNTech. BioNTech will be developing, manufacturing...
Scholar Rock’s $92.5 Million Common Stock Offering
Goodwin advised Scholar Rock Holding Corporation on the offering. Scholar Rock Holding Corporation (Nasdaq: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious...
Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction. Novo Nordisk A/S and KBP...
Standard BioTools’ Merger with SomaLogic
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
Orionis Biosciences’ Collaboration with Genentech
Goodwin Procter advised Orionis Biosciences on the collaboration with Genentech. Privately held Orionis Biosciences announced a multi-year collaboration with Genentech, a member of the Roche Group, to discover...
Seagen and Nurix’s Strategic Collaboration
Goodwin advised Seagen on the deal. Nurix Therapeutics, Inc. (Nasdaq: NRIX) announced that it has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc....
Clari’s Acquisition of Groove
Fenwick & West represented Clari in the transaction. Clari announced the acquisition of Groove, a market leader in sales engagement. The integration of Groove’s sales engagement capabilities...